This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Glucosamine Sulphate and Increased Level of Blood Cholesterol

This study has been completed.
Pharma Nord
Information provided by:
Slidgigtinstituttet Identifier:
First received: November 7, 2005
Last updated: NA
Last verified: July 2005
History: No changes posted
Glucosamine sulphate causes no changes in blood levels of cholesterol

Condition Intervention Phase
Osteoarthritis Drug: Glucosamine sulphate Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Glucosamine Sulphate and Hypercholesterolaemia

Resource links provided by NLM:

Further study details as provided by Slidgigtinstituttet:

Primary Outcome Measures:
  • Levels of blood cholesterol

Secondary Outcome Measures:
  • Effect of treatment on pain

Estimated Enrollment: 66
Study Start Date: April 2005
Estimated Study Completion Date: August 2005
Detailed Description:
The effects on glucosamine sulphate on blood levels of choleterol is measuered in patients with mild to moderate osteoarthritis

Ages Eligible for Study:   40 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria: Osteoarthritic pain, normal blood cholesterol levels -

Exclusion Criteria: Systemic diseases, pregnancy, need of medication besides painkillers

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00251069

Ishøj, Denmark, DK-2635
Sponsors and Collaborators
Pharma Nord
Principal Investigator: Keld Ostergaard, M.D., Ph.D. Slidgigtinstituttet
  More Information Identifier: NCT00251069     History of Changes
Other Study ID Numbers: EudraCTnr 2005-000541-11
Study First Received: November 7, 2005
Last Updated: November 7, 2005

Keywords provided by Slidgigtinstituttet:
glucosamine sulphate, osteoarthritis, cholesterol,

Additional relevant MeSH terms:
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases processed this record on July 19, 2017